Raif Derrazi Interviews Jeff Galvin on HIV Clinical Trial Updates & Addimmune 


CEO Jeff Galvin joins HIV activist and Youtube creator Raif Derrazi to discuss the launch of Adimmune™ – a new HIV-focused spinoff company that will focus solely on advancing an HIV cure, building upon more than a decade of work by American Gene Technologies® (AGT™). Galvin provides insights on data from AGT’s HIV Phase I clinical trial, as well as why Addimmune was created to continue the HIV research.

Be Part of Our Mission to Make an Impact

Sign up for our newsletter and follow our journey to potentially eradicate HIV with our gene therapy.

Subscribe Here!


Scroll to Top